Political Quotes

On the recordOctober 22, 2015
Mr. President, I thank my colleagues for allowing me the time. Very quickly, it was said that this bill will not prevent and would not have prevented the attacks that took place at American companies. It is, in fact, right. The vice chair and I have never portrayed that this was a prevention bill. We said it is not a prevention bill. It is a bill designed to share information to minimize the loss of data. As it relates to personal data, my colleague from Oregon forgets that the managers' amendment strengthens by making sure on the government side that they only draw in the fields that the entire government collaborative group agrees need to be used for forensic purposes over and above what Senator Carper pointed out are the responsibilities of the private sector companies. It was said that the vice chair and I have been critical of technology companies that oppose this bill. I don't think we have been critical. We have been confused--confused that the companies that hold the most personal data on the American people in the country want to deprive every other business in America from having the ability to share their information when they are hacked. So I am not critical. I am challenged to figure out why they would take that position, but I have come to the conclusion that there are some questions in life that have no answers, and I have now reached one of those.…
Said by
Richard Burr
Republican · North Carolina

Share & report

More from Richard Burr

Feb 15, 2022

Mr. President, I actually rise today to support Bob Califf and to say to my colleagues there has been a lot of criticism as to what he has done. I have never seen an FDA Commissioner, in 9 months of service--that was the length of his time…

Congressional Record · 2022-02-15
Apr 4, 2022

I question whether the agreements both passed and proposed reflect a good deal for patients they are designed to serve.

congress.gov
Apr 25, 2022

Without Orrin, we wouldn't have a generic drug industry.

congress.gov
Apr 4, 2022

What does it mean for a small company when FDA misses these goals, and what does it mean to patients?

congress.gov

Other voices in this conversation